Nayan K Zinzuwadia, MD | |
306 Stanaford Rd, Beckley, WV 25801-3142 | |
(304) 255-3000 | |
Not Available |
Full Name | Nayan K Zinzuwadia |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 38 Years |
Location | 306 Stanaford Rd, Beckley, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538159066 | NPI | - | NPPES |
050073741 | Other | WV | RR MEDICARE |
001722370 | Other | WV | BLUE CROSS |
55076731800 | Other | WV | W COMP |
5700331000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 19977 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
United Hospital Center | Bridgeport, WV | Hospital |
Welch Community Hospital | Welch, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Appalachian Mountains Medical Llc | 6709016264 | 32 |
United Hospital Center Inc | 8123936010 | 209 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D touch-enabled modeling systems, dental CAD/CAM solutions and haptic devices, has announced that it will be offering a second, fully integrated scanner option for the SensAble Dental Lab System, as well as SensAble's new OpenScan™ software interface. The new scanner supports the scanning of both models and impressions, providing a high degree of flexibility for labs and allowing further time-savings.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
A new study from iPSYCH shows that the infections children contract during their childhood increase the risk of mental disorders during childhood and adolescence. This knowledge expands our understanding of the role of the immune system in the development of mental disorders.
Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 7 days ago
Entity Name | United Hospital Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760965586 PECOS PAC ID: 8123936010 Enrollment ID: O20031212000802 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D touch-enabled modeling systems, dental CAD/CAM solutions and haptic devices, has announced that it will be offering a second, fully integrated scanner option for the SensAble Dental Lab System, as well as SensAble's new OpenScan™ software interface. The new scanner supports the scanning of both models and impressions, providing a high degree of flexibility for labs and allowing further time-savings.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
A new study from iPSYCH shows that the infections children contract during their childhood increase the risk of mental disorders during childhood and adolescence. This knowledge expands our understanding of the role of the immune system in the development of mental disorders.
Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 7 days ago
Entity Name | Appalachian Anesthesia Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346230877 PECOS PAC ID: 1254379647 Enrollment ID: O20050418000318 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D touch-enabled modeling systems, dental CAD/CAM solutions and haptic devices, has announced that it will be offering a second, fully integrated scanner option for the SensAble Dental Lab System, as well as SensAble's new OpenScan™ software interface. The new scanner supports the scanning of both models and impressions, providing a high degree of flexibility for labs and allowing further time-savings.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
A new study from iPSYCH shows that the infections children contract during their childhood increase the risk of mental disorders during childhood and adolescence. This knowledge expands our understanding of the role of the immune system in the development of mental disorders.
Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 7 days ago
Entity Name | Appalachian Mountains Medical Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881023117 PECOS PAC ID: 6709016264 Enrollment ID: O20140228000564 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D touch-enabled modeling systems, dental CAD/CAM solutions and haptic devices, has announced that it will be offering a second, fully integrated scanner option for the SensAble Dental Lab System, as well as SensAble's new OpenScan™ software interface. The new scanner supports the scanning of both models and impressions, providing a high degree of flexibility for labs and allowing further time-savings.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
A new study from iPSYCH shows that the infections children contract during their childhood increase the risk of mental disorders during childhood and adolescence. This knowledge expands our understanding of the role of the immune system in the development of mental disorders.
Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Nayan K Zinzuwadia, MD Po Box 787, Crab Orchard, WV 25827-0787 Ph: (304) 253-5793 | Nayan K Zinzuwadia, MD 306 Stanaford Rd, Beckley, WV 25801-3142 Ph: (304) 255-3000 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D touch-enabled modeling systems, dental CAD/CAM solutions and haptic devices, has announced that it will be offering a second, fully integrated scanner option for the SensAble Dental Lab System, as well as SensAble's new OpenScan™ software interface. The new scanner supports the scanning of both models and impressions, providing a high degree of flexibility for labs and allowing further time-savings.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
A new study from iPSYCH shows that the infections children contract during their childhood increase the risk of mental disorders during childhood and adolescence. This knowledge expands our understanding of the role of the immune system in the development of mental disorders.
Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 7 days ago
Dr. Miguel A. Montejo, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1802 Harper Rd, Suite 102, Beckley, WV 25801 Phone: 304-894-8817 Fax: 304-894-8924 | |
Vinod B Parmar, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 306 Stanaford Rd, Beckley, WV 25801 Phone: 304-255-3000 | |
Dr. Bruce W Cannon, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 1710 Harper Rd, Beckley, WV 25801 Phone: 800-277-8151 |